DOSSIER · 13F Holders · Q2 2026
INM
INMED PHARMACEUTICALS INC
17 institutions still hold INMED PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 457637700·17 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
17 institutions reported INM in Q2 2026. ADAR1 Capital Management, LLC leads at 37.3% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.